Results 111 to 120 of about 22,260 (249)

Increased Anti‐Psoriatic Effect of Anti‐Inflammatory Dendrimers Using Fluid Catanionic Vesicle‐Based Topical Formulations

open access: yesAdvanced Healthcare Materials, Volume 15, Issue 9, 6 March 2026.
Next‐Generation Psoriasis Therapy – With advanced dendrimer‐based formulations, this study paves the way for highly effective, skin‐permeable treatments. Encapsulated in fluid catanionic vesicles, IMD‐006 and its analogues show promising anti‐psoriatic effects offering a targeted, non‐invasive approach to managing chronic skin inflammation.
Ranime Jebbawi   +10 more
wiley   +1 more source

Precise Construction of an Antimicrobial Peptide Targeting Bacterial Cell Membranes Derived From Natural Peptides

open access: yesAdvanced Science, Volume 13, Issue 17, 23 March 2026.
An AMP (P 3‐3R‐8I) based on natural peptides, which can target bacterial cell membranes, was precisely constructed via amino acid mutation. P 3‐3R‐8I exhibits antibacterial capability which could be attributed to the ability of P 3‐3R‐8I to quickly penetrate bacterial cell membranes and then to bind to bacterial DNA.
Jiaqi Huang   +11 more
wiley   +1 more source

How Supply Networks Influence Sustainable Innovation: Evidence From Ghana's Public Works Procurement

open access: yesBusiness Strategy and the Environment, Volume 35, Issue 3, Page 4309-4327, March 2026.
ABSTRACT Recent environmental and sustainability standards in procurement increase short‐term production and operational costs to suppliers, which are often recouped by charging price premiums for innovative solutions. However, public buyers are less likely to pay such price premiums, resulting in a disincentive among suppliers to bid for innovation ...
Peter Adjei‐Bamfo   +5 more
wiley   +1 more source

Identity Salience and Field‐Course Engagement: From Deficits to Assets

open access: yesEcology and Evolution, Volume 16, Issue 3, March 2026.
To address inequities in STEM, field courses should therefore be investigated to better understand students who are underrepresented in the disciplines—whether based on their nationality, socioeconomic background, race or ethnicity, their gender identity or sexuality, etc.
Alyssa N. Olson   +3 more
wiley   +1 more source

T.06.4 LONG TERM EFFICACY AND SAFETY OF ABP 501 ADALIMUMAB BIOSIMILAR ON INFLAMMATORY BOWEL DIESASES: THE ADASWITCH STUDY

open access: green, 2022
A. Cingolani   +14 more
openalex   +2 more sources

Engineered Probiotics: The Next‐Generation Therapeutics to Combat Antibiotic‐Resistant Bacterial Infections

open access: yesFood Frontiers, Volume 7, Issue 2, March 2026.
Engineered probiotics secretes fusion proteins which potentially neutralized the toxins secreted by other microbial communities. ABSTRACT On a global scale, the escalating burden of infectious diseases, predominantly attributed to bacterial pathogens, especially drug‐resistant strains, has progressed into a critical concern for clinical management and ...
Indu Singh   +11 more
wiley   +1 more source

Effect of L‐Citrulline Intake on Blood Pressure in Cold Environments: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

open access: yesFood Science &Nutrition, Volume 14, Issue 3, March 2026.
This study investigated the effect of L‐citrulline supplementation on BP under cold exposure and found that it significantly reduced both SBP and DBP, thereby alleviating cold‐induced hypertension, thus providing a scientific basis for cardiovascular protection. Future studies should further investigate its optimal dosage.
Ping Luo   +3 more
wiley   +1 more source

Cerebral in situ ischemic postconditioning: From bench to bedside and beyond

open access: yesNeuroprotection, Volume 4, Issue 1, Page 48-64, March 2026.
This review explores the translational potential of in situ ischemic postconditioning in acute ischemic stroke. Preclinical and clinical evidence is summarized to highlight its promise as a neuroprotective strategy in the era of endovascular therapy.
Xiao Jiang   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy